We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANL icon
2326
Pangaea Logistics
PANL
$484M
$245K ﹤0.01%
+41,693
New +$250K
HCC icon
2327
Warrior Met Coal
HCC
$4.17B
$244K ﹤0.01%
6,658
+143
+2% +$5.29K
AAXJ icon
2328
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
$244K ﹤0.01%
+3,600
New +$246K
CNR
2329
Core Natural Resources Inc
CNR
$3.93B
$244K ﹤0.01%
4,184
-23,861
-85% -$1.36M
KNOP icon
2330
KNOT Offshore Partners
KNOP
$354M
$244K ﹤0.01%
+45,452
New +$292K
VNT icon
2331
Vontier
VNT
$4.54B
$244K ﹤0.01%
+8,909
New +$215K
PXS icon
2332
Pyxis Tankers
PXS
$47M
$244K ﹤0.01%
49,595
+27,989
+130% +$147K
FTXN icon
2333
First Trust Nasdaq Oil & Gas ETF
FTXN
$163M
$242K ﹤0.01%
8,980
-87
-1% -$2.4K
GLRE icon
2334
Greenlight Captial
GLRE
$579M
$242K ﹤0.01%
+25,791
New +$243K
TT icon
2335
Trane Technologies
TT
$98.8B
$239K ﹤0.01%
1,300
-72,514
-98% -$13.2M
SPTM icon
2336
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.3B
$238K ﹤0.01%
+4,720
New +$233K
GCT icon
2337
GigaCloud Technology
GCT
$1.55B
$238K ﹤0.01%
+37,752
New +$208K
DRS icon
2338
Leonardo DRS
DRS
$12.4B
$236K ﹤0.01%
+18,175
New +$235K
CRS icon
2339
Carpenter Technology
CRS
$26.4B
$234K ﹤0.01%
+5,232
New +$238K
CVRX icon
2340
CVRx
CVRX
$131M
$234K ﹤0.01%
+25,085
New +$332K
FTCI icon
2341
FTC Solar
FTCI
$41.6M
$233K ﹤0.01%
10,360
-4,610
-31% -$123K
SANM icon
2342
Sanmina
SANM
$8.78B
$232K ﹤0.01%
3,807
-30,732
-89% -$1.84M
ITB icon
2343
iShares US Home Construction ETF
ITB
$2.32B
$232K ﹤0.01%
+3,300
New +$223K
CTAS icon
2344
Cintas
CTAS
$86.6B
$231K ﹤0.01%
2,000
-15,932
-89% -$1.76M
ACTG icon
2345
Acacia Research
ACTG
$437M
$231K ﹤0.01%
59,930
-117,941
-66% -$499K
PRAX icon
2346
Praxis Precision Medicines
PRAX
$8.11B
$230K ﹤0.01%
+18,913
New +$798K
HEWJ icon
2347
iShares Currency Hedged MSCI Japan ETF
HEWJ
$713M
$229K ﹤0.01%
7,940
-4,200
-35% -$117K
RIGL icon
2348
Rigel Pharmaceuticals
RIGL
$723M
$228K ﹤0.01%
+17,273
New +$274K
CANO.WS
2349
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$228K ﹤0.01%
250,000
-67,010
-21% -$19.7K
LUMN icon
2350
Lumen
LUMN
$6.43B
$227K ﹤0.01%
85,696
-4,939,062
-98% -$19.9M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.